GWPH - Better Buy: GW Pharmaceuticals vs. Aurora Cannabis
Aurora Cannabis (NYSE: ACB) and GW Pharmaceuticals (NASDAQ: GWPH) are two cannabis companies seemingly going in different directions. It's not just their strategies that are different; so are their financials and their stock performances. Year to date, Aurora has lost more than half of its value and while GW has struggled in recent months, it's flat over the same period.
With cannabis stocks in the spotlight for all the wrong reasons as of late, it's more important than ever for investors to find the right stock to invest in today. Let's take a close look at each of these two stocks to see which one is the better long-term buy today.
GW is a medical marijuana stock, and while that may make some investors discount its growth potential, that shouldn't be counted against the company. After all, GW is the first and only company to have a cannabis-based drug (Epidiolex) approved by the U.S. Food and Drug Administration. GW has also made significant progress in Europe, where the drug recently received approval, allowing the company to sell the drug in more than two dozen countries.